AbbVie

Open: 141.89 Close: 141.2 Change: -0.69

Try an AI to get informed about investing in AbbVie.

This document will help you to evaluate AbbVie without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, stock, Inc, market, Futures, Abbvie, company, and the …

Concept Map

Semantic Network

Stock Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenos.

Today's Summary

AbbVie Inc. is celebrating the fifth annual BOTOX® Cosmetic (onabotulinumtoxinA) Day is Back Like Never Before. The company raised its annual profit forecast for fiscal 2023. Abbvie is 107.82% away from the 52-week low.

Today's News

AbbVie Inc. is celebrating the fifth annual BOTOX® Cosmetic (onabotulinumtoxinA) Day is Back Like Never Before. The information in the press releases on these pages was factually accurate on the date of publication. AbbVie Inc. per Employee $1.103M P/E Ratio 38.58 P/P ratio 38.66 Yield 4.39% Dividend $1.55 Ex-Dividend Date Jan 12, 2024 Short Interest 11.47M 10/13/23 % of Float Shorted 0.65% Performance 5 Day -0.49% 1 month -5.30% 10 Hind iRECT optimize luxurious Costa join usheridis subt AbbVie Inc. markets closed S&P Futures 4,375.00 -9.25 (-0.21%) Dow Futures 34,089.00 (-75.00%) Nasdaq Futures 15,210.25 -22.25 (0.15%) Russell 2000 Futures 1,742.50 (-3.10%) Crude Oil 8046 -0.46 (Cider famously Jaime Double Hover Charles pedd heck Twitch TF tu239 pap AbbVie is headquartered in North Chicago, Illinois, the US. As of November 2023 Abbvie has a market cap of $249.29 Billion. This makes the company the 35th most valuable company by market cap. Ironwood and AbbVie co-develop and co-commercialize LINZESS for the treatment of adults with IBS-C or CIC. In Europe, Abbvie markets linaclotide under the brand name CONSTELLA® for the. treatment of. adults with moderate to severe IBS.C. in Europe. AbbVie Inc. (ABBV) stock price, quote & news - stock analysis. Abbvie Inc.s stock price is $58.05 billion, an increase 330% compared to the previous years. The company was $58 billion in 2012. AbbVie raises earnings guidance for fiscal 2023. The company raised its annual profit forecast. AbbVie stock has received a consensus rating of buy. The 48 analysts offering price forecasts for Abbvie stock have a median target of 166.50, with a high estimate of 200.00 and a low estimate of 113.00. According to the current price, Abvie is 107.82% away from the 52-week low. AbbVie enters option deal for Aldeyra dry eye disease drug (NYSE:ABBV) The deal has transformed Abbvies portfolio by lowering its dependence on Humira, its flagship product.

Stock Profile

"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; and Genentech, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois."

Keywords

Are looking for the most relevant information about AbbVie? Investor spend a lot of time searching for information to make investment decisions in AbbVie. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, stock, Inc, market, Futures, Abbvie, company, and the most common words in the summary are: abbvie, stock, market, job, inc, news, buy, . One of the sentences in the summary was: AbbVie Inc. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #abbvie #stock #market #job #inc #news #buy.